This paper examines eczema (atopic dermatitis) as an immune-mediated inflammatory condition characterized by abnormally high IgE levels and hypersensitivity to common allergens. It explains the pathophysiology of eczema, including skin barrier dysfunction and the role of mast cells in allergic reactions. The paper also explores the genetic basis of atopy, the link between eczema and hay fever, the structure and function of IgE antibodies, and diagnostic methods such as skin prick testing. Finally, it addresses the broader context of living with eczema and its connection to other atopic conditions like asthma.
Eczema is defined as "a form of dermatitis, an inflammation of the epidermis." A typical case presents with vesicles in the skin initially, followed by edema, papules, and crusting. Eczema is not a disease but a reaction pattern with many causes. It is also known as atopic dermatitis, meaning there is an abrupt hypersensitivity to antigens mediated by raised IgE levels. However, other types of eczema exist, each with distinct origins.
The pathophysiology of eczema involves swelling within the epidermis due to separation of keratinocytes by fluid accumulating between them. This leads to hyperkeratosis, which results in clinical scales. The itching characteristic of eczema, when repeatedly mechanically stimulated, causes damage to the skin barrier and increases water loss. Once the barrier is compromised, materials can more easily pass into the epidermis, eliciting an allergic response. This creates a self-perpetuating cycle: itching leads to scratching, barrier damage accelerates allergen penetration, and further immune activation increases itching.
Atopy is an allergic hypersensitivity that enables affected individuals to produce abnormally high levels of IgE in response to common proteins such as dust mites. Atopy has a strong hereditary trait, being more likely to be passed on from an affected mother than an affected father. Siblings who inherit the trait may show different symptoms or may be entirely unaffected. For example, one child may develop eczema while another develops hay fever, or both conditions may occur.
The manifestation of atopy varies widely among genetically susceptible individuals. While some patients outgrow skin symptoms, approximately three-quarters of patients go on to develop other reactions such as hay fever and asthma. People with atopy can develop asthma in response to fungal spores, eczema in response to house mites, and hay fever in response to grass pollen. This phenotypic heterogeneity reflects the complex interplay between genetic predisposition and environmental exposure.
Hay fever, less commonly known as allergic rhinitis, is caused by airborne substances and characterized by itching eyes, rhinitis, and sneezing. In atopic patients, airborne substances trigger a reaction by IgE antibodies, causing mast cells to degranulate. The primary cause of hay fever symptoms is histamine, which is released from mast cells upon activation.
Patients with atopic dermatitis already have raised IgE levels, some of which are bound to mast cells in tissues. Mast cells are therefore primed to react as soon as IgE comes into contact with an allergen—for example, grass pollen. This explains why patients with atopic dermatitis are significantly predisposed to developing hay fever and other atopic manifestations. The elevated baseline IgE establishes a state of immune readiness that facilitates rapid allergic responses to inhaled and ingested allergens.
"Antibody structure and immune response pathways"
"Testing and long-term atopic disease outcomes"
Always verify citation format against your institution’s current style guide requirements.